Bioventus Inc. (BVS) Financials

BVS Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 673.3 million 395.9 million
March 31, 2026 650.5 million 416.3 million
Dec. 31, 2025 683.6 million 455.1 million
Sept. 30, 2025 701.6 million 494.3 million

BVS Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 18.9 million 5.0 million
March 31, 2026 8.4 million 3.3 million
Dec. 31, 2025 37.4 million 3.4 million
Sept. 30, 2025 29.6 million 3.2 million

BVS Net Income

No data available :(

BVS Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 29.5 million 229.7 million 15.3 million
March 31, 2026 35.8 million 253.3 million -
Dec. 31, 2025 51.2 million 279.0 million 13.2 million
Sept. 30, 2025 42.2 million 311.3 million -

BVS Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 70.8 million
March 31, 2026 70.0 million
Dec. 31, 2025 68.9 million
Sept. 30, 2025 68.8 million

BVS Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 960000 3.2 million 82.7 million -
March 31, 2026 574000 2.5 million 78.3 million -
Dec. 31, 2025 580000 3.0 million 82.8 million -
Sept. 30, 2025 473000 2.9 million 77.8 million -

BVS Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 153.2 million 47.5 million
March 31, 2026 132.1 million 42.4 million
Dec. 31, 2025 157.9 million 50.4 million
Sept. 30, 2025 138.7 million 45.8 million

BVS Revenue by Segment
Graph available only for paid members. Upgrade to see it.

BVS

Price: $12.69

52 week price:
6.37
15.89

Payout Ratio Range:
-157.39%
216.97%

Earnings Per Share: 0.77 USD

P/E Ratio: 18.13

Exchange: NMS

Sector: Healthcare

Industry: Medical Devices

Market Capitalization: 889.5 million

Links: